The RET/PTC3 rearrangement is formed by fusion of the ELE1 and RET genes, and is highly prevalent in radiation-induced post-Chernobyl papillary thyroid carcinomas. We characterized the breakpoints in the ELE1 and RET genes in 12 post-Chernobyl pediatric papillary carcinomas with known RET/PTC3 rearrangement. We found that the breakpoints within each intron were distributed in a relatively random fashion, except for clustering in the Alu regions of ELE1. None of the breakpoints occurred at the same base or within a similar sequence. There was also no evidence of preferential cleavage in AT-rich regions or other target DNA sites implicated in illegitimate recombination in mammalian cells. Modi®cation of sequences at the cleavage sites was minimal, typically involving a 1 ± 3 nucleotide deletion and/or duplication. Surprisingly, the alignment of ELE1 and RET introns in opposite orientation revealed that in each tumor the position of the break in one gene corresponded to the position of the break in the other gene. This tendency suggests that the two genes may lie next to each other but point in opposite directions in the nucleus. Such a structure would facilitate formation of RET/PTC3 rearrangements because a single radiation track could produce concerted breaks in both genes, leading to inversion due to reciprocal exchange via endjoining.
Introduction
The Chernobyl nuclear power accident in April 1986 produced one of the most serious environmental disasters ever recorded and created a rich paradigm of radiation-induced human neoplasia, oering remarkable insights into thyroid carcinogenesis (Kazakov et al., 1992; Nikiforov and Gnepp, 1994; . We and others observed that a speci®c type of the RET gene rearrangement, RET/PTC3, is highly prevalent (50 ± 58%) in post-Chernobyl pediatric papillary carcinomas removed 5 ± 7 years after the accident (Klugbauer et al., 1995; Fugazzola et al., 1995; Nikiforov et al., 1997) , but not in tumors from unexposed children (Bongarzone et al., 1996; Nikiforov et al., 1997) . We have also found that this type of RET rearrangement is associated with a speci®c histotype of radiation-induced thyroid tumors ± the solid growth papillary carcinoma, that is rare in sporadic adult or pediatric populations (Nikiforov et al., 1997) . On the other hand, RAS and p53 mutations, prevalent in sporadic thyroid cancers, are virtually absent among post-Chernobyl tumors (Nikiforov et al., 1996; Suchy et al., 1998) . Thus, RET/PTC3 rearrangement is a major genetic event in a well-characterized population of radiation-induced post-Chernobyl pediatric papillary carcinomas and most likely has direct association with radiation exposure.
RET/PTC3 results from a paracentric inversion of the long arm of chromosome 10 and is formed by fusion of the intracellular domain of RET tyrosine kinase receptor gene with the ELE1(RFG) gene (Santoro et al., 1994) . Both genes are located at 10q11.2, with a minimum distance of 500 kb between them (Minoletti et al., 1994) . The ELE1 gene is expressed ubiquitously and drives the expression of the truncated RET receptor in thyroid follicular cells.
The precise mechanisms of how radiation may induce oncogenic mutations, such as RET/PTC3 rearrangement, and lead to papillary thyroid carcinoma development are unknown. One possibility is that radiation directly caused the mutation as a result of misrepaired DNA damage. It is well known that radiation produces a random pattern of primary particle tracks, that (by direct ionization and through the agency of chemical radicals) cause damage to the chromatin structure manifesting as single-strand DNA breaks, double-strand DNA breaks, base damage and DNA-protein crosslinks (Ward, 1988; Kovacs et al., 1994; Grosovsky et al., 1988) . DNA strand breaks can be lethal to the cell, and several enzymatic mechanisms exist to repair them. One such repair mechanism is to ligate the ends of severed chromosomes (end-joining). Incorrectly rejoined breaks may result in chromosomal aberrations such as chromosomal translocations, deletions, and inversions, through which an oncogene (such as the RET/PTC3 fusion gene) can form. Indeed, the induction of the RET gene rearrangement has been observed in human fetal thyroid tissue transplanted into SCID mice as early as 2 days following 50 Gy exposure (Mizuno et al., 1997) . The direct action model or radiation-induced cancer does not explain the long period of time between radiation exposure and development of the disease, but this lag period would be expected if the RET/PTC3 fusion is necessary, but not sucient to cause tumor growth. The lag period would be the time required for a second genetic event to occur. Indeed, it has been shown that constitutive expression of RET/PTC1 (another form of RET rearrangement also leading to the activation of the truncated RET receptor) in well-dierentiated thyroid PCCL3 cells was associated with loss of dierentiated properties, but was not sucient for transformation (Santoro et al., 1993) . However, malignant phenotype was obtained by cotransfection with H-RAS or K-RAS oncogenes.
An alternative to the direct pathway is that radiation does not act directly to produce the RET/PTC3 fusion, but instead may cause persistent genomic instability, which eventually produces one or more mutations that result in tumor progression (reviewed in Nikiforov and Fagin, 1998) .
Whether the gene fusion occurs early or late in the process of tumor cell evolution, two general mechanisms for such fusions are possible. One mechanism would be for concerted breaks to form in the RET and ELE1 genes. The RET/PTC3 fusion could then be formed by end-joining. This mechanism would be expected to be reciprocal. Concerted breaks could form as the direct result of radiation damage, or due to the action of an endonuclease. The alternative pathway to gene fusion would be for breaks to occur independently and to be joined at random. This mechanism would not be expected to produce reciprocal rearrangements.
To explore the potential mechanisms causing the RET/PTC3 fusion in radiation-induced tumors, we identi®ed and analysed the precise breakpoint sites in the RET and ELE1 gene in 12 pediatric postChernobyl papillary thyroid carcinomas. The structures of these breakpoints were most consistent with the direct mechanism of induction of RET/PTC3 fusion via reciprocal exchange at a pair of double strand breaks which are in proximity to each other due to the folding of the chromosome 10.
Results
A series of PCRs with all possible combinations of primers located sequentially through intervals of 200 ± 250 bp across ELE1 intron 5 (1670 bp) and RET intron 11 (1843 bp) was performed to amplify genomic DNA from each tumor (Figure 1 ). The ampli®cation product containing ELE1/RET breakpoint was obtained in 12 of 22 tumors. The breakpoint sites within the two genes were identi®ed by sequencing of PCR products. Then, the reciprocal sequence of RET/ELE1 was obtained. Comparison of the nucleotide composition of the chimeric introns in each tumor with both contributing germline sequences allowed us to deter- Figure 1 Strategy for breakpoint site identi®cation by PCR ampli®cation of genomic DNA from tumors with RET/PTC3 using all possible combinations of the forward primers (F1 ± F7) and the reverse primers (R1 ± R7) Figure 2 Nucleotide sequences of ELE1/RET and RET/ELE1 breakpoint sites in 12 tumors and germ-line sequences of the ELE1 and RET genes. Arrows indicate positions of the breakpoints. Nucleotides deleted or inserted (duplicated) are shown in boxes. Short-sequence homology between germline RET and ELE1 sequences in the proximity of the breakpoint sites are indicated in italics and underlined mine the precise composition of the breakpoints and modi®cation of sequences at these sites ( Figure 2 ). The location and distribution of the breakpoint sites in the RET or ELE1 genes are shown in Figure 3 .
Analysis of these data revealed that breakpoints in the ELE1 gene were asymmetrically distributed, with nine of 12 breakpoints located in the right half of the intron. Most of this half of the intron is occupied by two Alu sequences, and eight breakpoints fell within one or the other of these two SINES. Breakpoints in the RET intron 11 were distributed more evenly along the intron, with four cases (C2, C15, C28, C24) clustered within an 80 bp region.
None of the RET or ELE1 breakpoints occurred at exactly the same base or within a similar sequence in any of the 12 tumors.
There was no long-sequence homology between regions contributing to these rearrangements, indicating that they are the result of illegitimate rather than homologous recombination. Short-sequence homology (3 ± 5 nucleotides) was found at or immediately adjacent to breakpoints in seven cases.
Each of these inversions was formed via a fairly precise reciprocal recombination event. Modi®cation of sequences at the breakpoint sites was minimal, typically involving a 1 ± 3 nucleotide deletion and/or duplication. Four cases had suered larger deletions of 9 ± 98 bp.
Breakpoints exhibited no particular nucleotide sequence or composition. In the ELE1 intron, breakpoint sites were located in regions with an average ATcontent of 52%, close to the AT-content of the entire intron, which is 61%. The same was true for the RET intron, where breakpoints occurred within regions with 37% AT-content, the same as the AT-content of the entire intron. Only one of 12 breakpoints in ELE1 gene was located within a 214 bp AT-rich region (76% AT) at the 5'-end of the intron. Two of the 24 breakpoint sites in both genes were found at or close to a poly-A sequence (C8 and C30 in ELE1), and one breakpoint was found within a run of six T residues (C11 in ELE1). Short purine/pyrimidine tracts were seen at two rearrangement sites (C20, C24). Other direct repeats, palindromes, chi-like minisatellite octamer sequences, or telomere-like repeats were not found at or close to breakpoint sites. No perfect vertebrate topoisomerase II consensus sequence occurs within either of the introns. However, if a 1 ± 3 bp mismatch is allowed, three of 24 breakpoint sites (C27 and C17 in ELE1, C24 in RET) were close to topoisomerase II recognition sites.
Thus, the breakpoint sites in each intron appeared to be distributed in a relatively random fashion. However, upon further analysis a certain pattern emerged. Despite the great range of the chimeric intron lengths (from 304 to 3240 bp), these fusion introns tended to be comprised of equal lengths of DNA from each gene. To illustrate, the 304 bp intron in the C20 fusion contained 152 bp from the ELE1 gene, and 152 bp from the RET gene. Similarly, the 3240 bp C14 intron contained 1517 bp from ELE1 and 1723 bp from the RET gene. Moreover, after alignment of the respective introns in opposite directions, the position of the breakpoint in one gene showed a correspondence to the position of the breakpoint in the other gene in each tumor (Figure 4) . As shown in Figure 4A , such an arrangement aligns ®ve of the breakpoint pairs directly across from each other. The other seven pairs of breakpoints can be aligned by sliding one gene with respect to the other ( Figure 4B and C). Interestingly, in the two other previously reported cases of Chernobyl-related cancers where fusion occurred between the ELE1 intron 5 and RET intron 11 (CH10 and CH4) (Bongarzone et al., 1997) , the breaks that were joined to form RET/PTC3 can also be aligned by this procedure (Figure 4 ).
Discussion
The analysis of the breakpoint sites in the RET and ELE1 genes composing RET/PTC3 rearrangement in these radiation-induced tumors suggests a direct mechanism of RET/PTC3 induction as a result of random double-strand DNA breaks produced by ionizing radiation, rather than a later occurrence of this mutation due to general destabilization of the genome. This, if the RET/PTC intrachromosomal inversion arose as a result of activation of the recombination machinery or errors in cleavage by enzymes that cut and join DNA (such as topoisomerase II), one would expect the breaks to be located within recombinase signal sequences at both participating loci, to have similarity in sequences at the breakpoints, or to be clustered at certain speci®c hypersensitive DNA regions such as AT-rich regions, Alu repeats, repeated purine/pyrimidine tracts, and other chromosomal regions with increased lability (fragile) sites (Ehrlich et al., 1993; Stary and Sarasin, 1992; Hyrien et al., 1987) . By contrast, our results indicate that in post-Chernobyl tumors the RET/PTC breakpoints were distributed relatively randomly across the respective introns, except for clustering in the Alu sequences of one of the two contributing genes, with no breakpoints occurring at exactly the same base or within an identical sequence in any of the 12 tumors. Although it is possible that cleavage within Alu regions favored recombination, the overall lack of consistency in speci®c DNA sites implicated in illegitimate recombination in mammalian cells suggests a direct induction of these genetic events as a result of random double-strand DNA breaks.
Despite the random distributions of the breakpoint sites in each intron, the alignment of two introns in opposite directions disclosed a certain pattern of correspondence of ELE1 and RET breaks in each tumor. In addition, breakpoint sites in RET/PTC3 in two previously reported post-Chernobyl cases (Bongarzone et al., 1997) showed similar patterns of correspondence. Such predictable relative positioning of chromosomal breaks in two dierent genes can occur if the chromosome is folded in a way to space these distant loci next to each other but pointed in opposite directions at the time of chromosomal breaks. In such cases, passage of a single radiation track can produce concerted double-strand DNA breaks in two chromosomal fragments closely spaced in the thyroid cell nucleus.
A number of studies indicate that chromosomes and their domains occupy distinct territories in interphase nuclei, rather than being randomly dispersed throughout the nuclear volume (Lichter et al., 1988; Pinkel et al., 1988) . Furthermore, chromosome arms and bands also form exclusive domains within a given territory (Cremer et al., 1996) . It has also been demonstrated that nuclear localization of centromeres and other discrete chromosomal regions is non-random, and varies between dierent phases of the cell cycle and according to the cell type (Manuelidis, 1984; Ferguson and Ward, 1992; Gerdes et al., 1994) . Moreover, it has been shown that for two random chromosomal loci the relationship between interphase distance and genomic separation was not always linear, leading to a model of chromatin arrangement in¯exible loops of several Mbp arranged along the chromosomal backbone (Yokota et al., 1995) .
Thus, although two chromosomal loci are located at a considerable linear distance from each other (such as the ELE1 and RET genes), they may be closely spaced in the interphase nucleus because of their position at speci®c areas of chromosomal loop(s).
The position of breakpoint sites in DNA recombination is thought to be determined mostly by sequencespeci®c factors, or secondary DNA structures at the breakpoint site. Thus, two distant regions consistently involved in a rearrangement event should possess a certain degree of nucleotide homology between them or contain recombinase-speci®c sequences at the cleavage site. However, the ELE1 and RET breakpoints do not display such features. Furthermore, our ®ndings suggest that the preferential occurrence of this rearrangement may be due in large part to the structural organization of the chromosome, resulting in the proximity of potentially recombinogenic DNA sequences during a certain stage of cell cycle. Schematic representation of the most possible mechanism of RET/PTC3 formation in these tumors is depicted in Figure 5 .
In conclusion, our ®ndings indicate that RET/PTC3 rearrangements in these radiation-induced tumors are a result of illegitimate reciprocal recombination. The simplest path to such events is ligation of ends that were produced by double-strand DNA breaks induced by radiation at the same time in the same place in a nucleus.
Materials and methods

Patient population
We studied 22 post-Chernobyl papillary thyroid carcinomas with RET/PTC3 rearrangements previously identi®ed by RT ± PCR (Nikiforov et al., 1997) . All patients resided in the areas of Belarus contaminated as a result of the Chernobyl nuclear accident in April, 1986. They underwent surgery at the Thyroid Tumor Center in Minsk, Belarus in 1991 and 1992. There were 15 males and seven females in this group. The age of patients at the time of surgery ranged from 5 ± 18 years. Figure 5 Putative mechanism of RET/PTC3 rearrangement based on the results of the current study. Schematic steps of RET/PTC3 formation starting from the linear arrangement of the wild-type genes in the long arm of chromosome 10 (top), to formation of chromosomal loop dextraposing the two genes adjacent to each other but pointed in opposite directions, to simultaneous breaks in both genes at the same sites with reciprocal exchange via end-joining leading to inversion and gene rearrangement as demonstrated in a linear fashion (bottom). Note that as a result of this reciprocal recombination the regions 1 and 2, internal to the target genes, are also inverted Identi®cation of breakpoints PCR-based approach was utilized to identify the precise breakpoint sites of RET/PTC3 rearrangement located within ELE1 intron 5 (1670 bp) and RET intron 11 (1843 bp). For these experiments, we determined that the quality of DNA extracted from paran-embedded tissue (performed as previously reported in Nikiforov et al., 1996) was sucient to amplify fragments of 400 ± 500 bp, and that the breakpoints in RET and ELE1 may occur at any site across the respective introns. Based on the reported sequences of RET intron 11 (GenBank Acc. # X77860) and ELE1 intron 5 (GenBank Acc. # X77859), we designed primers located sequentially through intervals of 200 ± 250 bp across both introns (Figure 1) . A series of PCRs in a ®nal volume of 20 ml with all possible combinations of upstream and downstream primers were performed to amplify the genomic DNA from each tumor as previously described (Nikiforov et al., 1996) . Ten ml of each PCR product were loaded on agarose gels, blotted to the nylon membranes and hybridized with an internal oligonucleotide probe end-labeled with 32 P (Nikiforov et al., 1997) . Another 10 ml of the PCR products were electrophoresed in an agarose gel and stained with ethidium bromide. The band of interest was excised, puri®ed, and sequenced with an automated ABI model 377 sequencer using the ABI PRISM Dye Terminator Cycle Sequencing kit (Perkin-Elmer, Foster City, CA, USA). If the initially identi®ed ampli®cation signal was larger than 500 bp or was visualized only after hybridization, additional internal primers were designed to narrow the region in order to facilitate sequencing.
After detecting the breakpoint sites in ELE1/RET we designed primers to obtain the reciprocal sequence of RET/ ELE1 for each tumor. PCR and sequencing techniques were identical to those described above. The position and nucleotide composition of primers for ELE1/RET and RET/ELE1, as well as of the oligonucleotide probes are available upon request.
Analysis of breakpoint sites and search for sequence features
The sequences obtained from each tumor where compared with the available germline sequences of the RET intron 11 and ELE1 intron 5 utilizing the DNAStar program (DNASTAR, Inc.) to identify the breakpoints sites in both genes, and to analyse possible modi®cation of nucleotide sequence at the breakpoint sites.
AT-rich regions, Alu sequences, direct DNA repeats, palindromes, purine/pyrimidine tracts, telomere-like repeats (TTAGGG) n , chi-like octamer conserved within minisatellite repeats (GG(A/T) GG(A/T)CG), as well as vertebrate topoisomerase II consensus sequences ((A/G)N(T/ C)NNCNNG(T/C)NG(G/T) TN(T/C)N(T/C)) were searched for in both introns and in the 100 bp of DNA surrounding each breakpoint.
